Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study by Tan, Z.W. (Zet Wei) et al.
1Tan ZW, et al. BMJ Open 2020;10:e038283. doi:10.1136/bmjopen-2020-038283
Open access 
Has the reporting quality of published 
randomised controlled trial protocols 
improved since the SPIRIT statement? A 
methodological study
Zet Wei Tan,1 Aidan Christopher Tan   ,2 Tom Li,1 Ian Harris,2 Justine M Naylor,2 
Michiel Siebelt,3 Jasper van Tiel,3 Marina Pinheiro,4 Laura Harris,5 
Kira Chamberlain,5 Sam Adie6
To cite: Tan ZW, Tan AC, Li T, 
et al.  Has the reporting quality 
of published randomised 
controlled trial protocols 
improved since the SPIRIT 
statement? A methodological 
study. BMJ Open 
2020;10:e038283. doi:10.1136/
bmjopen-2020-038283
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
038283).
Received 07 March 2020
Revised 18 July 2020
Accepted 21 July 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Sam Adie;  
 sam. adie@ gmail. com
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Objectives To determine the reporting quality of published 
randomised controlled trial (RCT) protocols before and 
after the Standard Protocol Items: Recommendations for 
Interventional Trials (SPIRIT) statement (2013), and any 
association with author, trial or journal factors.
Design Methodological study.
Data sources MEDLINE, Embase and CENTRAL were 
electronically searched using optimised search strategies.
Eligibility criteria Protocols written for an RCT of living 
humans, published in full text in a peer- reviewed journal 
and published in the English language.
Main outcome Primary outcome was the overall 
proportion of checklist items which were adequately 
reported in RCT protocols published before and after the 
SPIRIT statement.
Results 300 RCT protocols were retrieved; 150 from the 
period immediately before the SPIRIT statement (9 July 
2012 to 28 December 2012) and 150 from a recent period 
after the SPIRIT statement (25 January 2019 to 20 March 
2019). 47.9% (95% CI, 46.5% to 49.3%) of checklist items 
were adequately reported in RCT protocols before the 
SPIRIT statement and 56.7% (95% CI, 54.9% to 58.5%) 
after the SPIRIT statement. This represents an 8.8% (95% 
CI, 6.6% to 11.1%; p<0.0001) mean improvement in the 
overall proportion of checklist items adequately reported 
since the SPIRIT statement. While 40% of individual 
checklist items had a significant improvement in adequate 
reporting after the SPIRIT statement, 11.3% had a 
significant deterioration and there were no RCT protocols 
in which all individual checklist items were complete. 
The factors associated with higher reporting quality of 
RCT protocols in multiple regression analysis were author 
expertise or experience in epidemiology or statistics, 
multicentre trials, longer protocol word length and publicly 
reported journal policy of compliance with the SPIRIT 
statement.
Conclusion The overall reporting quality of RCT protocols 
has significantly improved since the SPIRIT statement, 
although a substantial proportion of individual checklist 
items remain poorly reported. Continued and concerted 
efforts are required by journals, editors, reviewers 
and investigators to improve the completeness and 
transparency of RCT protocols.
INTRODUCTION
Background
Randomised controlled trial (RCT) proto-
cols should permit prospective assessment of 
trial methodology, scientific integrity, ethical 
standards and safety considerations, public 
documentation of protocol changes and 
approved amendments, and retrospective 
validation of trial conduct and subsequent 
reporting.1 A well- written RCT protocol is 
an critical component of a high- quality RCT 
as it allows comparison between the initial 
inception, possible amendments and final 
publication. This supports RCT investigators 
and sponsors by improving research quality, 
ethics committees and journals by improving 
Strengths and limitations of this study
 ► We conducted a methodological study in accordance 
with a prospectively registered protocol (PROSPERO 
CRD42019126522).
 ► We assessed the reporting quality of two equal, 
arbitrary samples of 150 randomised controlled 
trial (RCT) protocols published before and after the 
SPIRIT (Standard Protocol Items: Recommendations 
for Interventional Trials) statement.
 ► Data extraction of the first 100 RCT protocols was 
independently duplicated by two investigators and 
any issues with data extraction were discussed at 
fortnightly round- table meetings attended by five 
investigators.
 ► The design of this study is limited by the lack of 
blinding of data collectors to the date of publication 
of RCT protocols and by the inclusion of only RCT 
protocols published in the English language.
 ► The associations found in this study may not be 
causal, and the improvements in overall reporting 
quality may be due to underlying secular trends 
whereby RCT protocol quality improves over time, 
unrelated to the introduction of the SPIRIT statement.
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research completeness, and participants and the public 
by improving research transparency.2
However, studies have frequently reported concerning 
inconsistencies between RCT protocols and their corre-
sponding publications,3–6 and serious deficiencies in the 
content of RCT protocols.5–13 Incomplete, inaccurate 
or undisclosed reporting of RCT protocols can result in 
research misrepresentation, selective outcome reporting 
and other biases which undercut the credibility and 
validity of health research and scientific knowledge.2 The 
SPIRIT (Standard Protocol Items: Recommendations for 
Interventional Trials) statement was published in January 
2013 and describes a 33- item minimum set of scientific, 
methodological, ethical and administrative components 
that should be routinely included in a trial protocol.1 It 
aims to address long- standing issues with the complete-
ness and transparency of many trial protocols by providing 
a standardised structure to trial plans, promoting strict 
accountability to trial conduct, improving the reliability 
and validity of trial outcomes, and facilitating the assess-
ment of risk of bias, methodological quality and reporting 
quality.1
Objectives
The impact of the SPIRIT statement on the reporting 
quality of RCT protocols in health research is unknown. 
The primary objectives of this study are to (1) deter-
mine the reporting quality of published RCT protocols 
before and after the SPIRIT statement and (2) determine 
whether author, trial or journal factors are associated with 
the reporting quality of published RCT protocols.
METHODS
Study design
We conducted a methodological study in accordance 
with a prospectively registered protocol (PROSPERO 
CRD42019126522).
Setting
RCT protocols were identified by electronically searching 
the bibliographic databases MEDLINE, Embase and 
CENTRAL using a search strategy formulated by an 
experienced medical librarian (online supplementary 
appendix A). All searches were performed independently 
by two investigators on 29 March 2019.
Included protocols
RCT protocols were eligible for inclusion if they were (a) 
written for an RCT of living humans, (b) published in full 
text in a peer- reviewed journal and (c) published in the 
English language. RCT protocols were excluded if they 
were (a) published only in protocol databases or online 
registries, or (b) reported any study results.
We screened RCT protocols until we retrieved two 
equal, arbitrary samples of 150 RCT protocols published 
before and after the SPIRIT statement. The sample of 150 
RCT protocols published immediately before the SPIRIT 
statement were retrieved by searching for RCT protocols 
published from 28 December 2012 and proceeding retro-
spectively until 150 eligible RCT protocols were selected. 
Similarly, the sample of 150 RCT protocols published 
recently since the SPIRIT statement were selected by 
searching for RCT protocols published from 20 March 
2019 and proceeding retrospectively until 150 eligible 
RCT protocols were retrieved. The titles and abstracts of 
all retrieved RCT protocols were independently screened 
by two investigators and the full texts of relevant RCT 
protocols were independently assessed for eligibility by 
two investigators. Any disagreements were resolved by 
discussion between the two investigators and, if required, 
arbitration by a third investigator. All eligible RCT proto-
cols were imported into EndNote X9 (Clarivate Analytics) 
software. Duplicates were removed by manually screening 
by author, year, title and journal.
Variables
The primary variables of interest were the checklist items 
from the SPIRIT statement, defined in the SPIRIT state-
ment explanation and elaboration.1 A data extraction 
form was developed based on the checklist items from the 
SPIRIT statement. Two checklist items (items 4 and 12) 
were subcategorised to reflect binary criterion and provide 
appropriate granularity. The checklist item ‘funding’ was 
split into ‘funding source’, defined as sources of financial, 
material and other support (eg, name and location of the 
funder), and ‘funding type’, defined as type of financial, 
material and other support (eg, funds, equipment, drugs 
and services). The checklist item ‘outcomes’ was split 
into ‘primary, secondary and other outcomes’ (eg, the 
specific measurement variable, analysis metric, method 
of aggregation and time point for each outcome), and 
‘explanation of clinical relevance of chosen efficacy and 
harm outcomes’. This resulted in a total of 53 individual 
checklist items. Each checklist item was assessed as either 
adequate or inadequate/unclear. The data extraction 
form and assessment criteria were independently piloted 
for ten randomly selected RCT protocols by five investiga-
tors. Disagreements were resolved by fortnightly round- 
table meetings attended by five investigators and the 
definitions of adequate and inadequate/unclear for each 
checklist item were revised accordingly.
The secondary variables of interest related to author, 
trial and journal factors. Author factors included the 
number of authors per protocol and the presence of 
authors with expertise or experience in epidemiology or 
statistics (defined as one or more authors with either a 
degree in clinical epidemiology, public health or biosta-
tistics, or an affiliation to a clinical epidemiology, public 
health or biostatistics department14 15). Trial factors 
included the total planned sample size, centre status 
(ie, multicentre or single centre), protocol word length 
(ie, greater or less than 3500 words) and funding source 
(ie, industry or non- industry funding). Protocol report 
of compliance with the SPIRIT statement and publicly 
reported journal policy of compliance with the SPIRIT 
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statement in the instructions to authors on the journal 
website, as of 2019, was also collected for RCT protocols 
published after the SPIRIT statement.
Data measurement
Data extraction was performed on the 300 RCT proto-
cols. Data extraction of the first 100 RCT protocols was 
independently duplicated by two investigators and data 
extraction of the remaining 200 RCT protocols was 
completed once between two investigators. Any issues 
with data extraction were discussed at fortnightly round- 
table meetings attended by five investigators.
Statistical methods
The final data points used for analysis were the results of 
the duplicate data collection and discussion of disagree-
ments. We performed descriptive analysis of the primary 
outcome by calculating the proportion (percentage) of 
checklist items which were adequately reported in RCT 
protocols. This was considered a measure of the overall 
reporting quality of RCT protocols. We also calculated 
the proportion (percentage) of RCT protocols which 
adequately reported each checklist item. Inter- rater 
agreement and kappa scores were calculated on the 
initial data points extracted by independent duplicate 
data collection (ie, before discussion of disagreements) 
of the first 100 RCT protocols. We performed exploratory 
multiple linear regression analysis to determine whether 
author, trial or journal factors were associated with the 
reporting quality of RCT protocols. Stepwise backward 
linear regression was performed, using p<0.25 as the 
criterion for inclusion in a multiple regression model, 
and R2 as the criterion for removal of variables in the 
backward elimination model. A p value <0.05 was consid-
ered statistically significant, and the R2 value was used as 
a measure of the final model goodness of fit. All statistical 
analyses were stratified by publication before or after the 
SPIRIT statement and were performed using Stata soft-
ware (StataCorp 2019, Stata Statistical Software: Release 
16, College Station, Texas, USA, StataCorp LP).
Patient and public involvement
As this was a study of RCT protocols, there was no 
patient or public involvement in the conception, design 
or conduct of the study, or the writing or editing of this 
paper.
RESULTS
Included protocols
A total of 300 RCT protocols were retrieved; 150 from 
before the SPIRIT statement (9 July 2012 to 28 December 
2012) and 150 from after the SPIRIT statement (25 
January 2019 to 20 March 2019). In the full- text eligibility 
assessment of RCT protocols published before the SPIRIT 
statement, 25 articles were excluded because they did not 
describe an RCT protocol, two because they had been 
retracted, one because it included study results, and one 
because it was not published in full- text. In the full- text 
eligibility assessment of RCT protocols published after 
the SPIRIT statement, six articles were excluded because 
they did not describe an RCT protocol. All excluded arti-
cles were replaced with eligible studies. The final 300 
RCT protocols were published across 45 peer- reviewed 
journals, with 46% (138/300) published in Trials.
The inter- rater agreement for data extraction of the 
first 100 RCT protocols ranged from 64.5% to 100%, with 
kappa scores provided in online supplementary appendix 
B. The individual checklist items with the lowest and 
highest inter- rater agreement were ‘statistical methods: 
statistical methods to handle missing data’ and ‘back-
ground and rationale: explanation for choice of compar-
ators’, respectively. The checklist items with the lowest 
and highest Kappa scores were ‘research ethics approval’ 
and ‘background and rationale: explanation for choice of 
comparators’, respectively.
Descriptive data
Author and trial characteristics were similar before and 
after the SPIRIT statement (table 1).
Of RCT protocols published after the SPIRIT state-
ment, 42.7% (64/150) self- reported compliance with the 
SPIRIT statement, and 88% (132/150) were published in 
a peer- reviewed journal with a publicly reported policy of 
compliance with the SPIRIT statement. Additionally, only 
17/300 (6%) of RCT protocols were published in jour-
nals which published in print, while the remainder (94%) 
were published in journals which published exclusively 
online. The mean word count of RCT protocols published 
in online journals and print journals was 4387 words and 
3581 words, respectively, with an 806 word difference in 
mean word count (95% CI, 26 to 1586 words, p=0.04).
Table 1 Author and trial characteristics before and after the 
SPIRIT statement
Before the 
SPIRIT 
statement
After the 
SPIRIT 
statement
Author characteristics
  Authors per protocol (median, 
range)
8, 1 to 90 8, 2 to 80
  One or more authors with 
expertise or experience in 
epidemiology or statistics (n, %)
50, 33.3% 48, 32%
Trial characteristics
  Total planned sample size 
(median)
214.5 200
  Multicentre status (n, %) 70, 46.7% 64, 42.7%
  Protocol word length >3500 (n, 
%)
105, 70% 106, 70.7%
  Industry funding (n, %) 8, 6% 10, 7%
SPIRIT, Standard Protocol Items: Recommendations for 
Interventional Trials.
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Outcome data
Of the 150 RCT protocols published before the SPIRIT 
statement, an average of 47.9% of checklist items per RCT 
protocol were adequately reported (95% CI, 46.5% to 
49.3%). Comparably, of the 150 RCT protocols published 
after the SPIRIT statement, an average of 56.7% of check-
list items were adequately reported (95% CI, 54.9% to 
58.5%). This represents an 8.8% (95% CI, 6.6% to 11.1%; 
p<0.0001) mean improvement in the overall proportion 
of checklist items adequately reported since the SPIRIT 
statement.
Of the 53 individual checklist items, 21 (40%) had a 
significant increase (p<0.05) in adequate reporting since 
the SPIRIT statement (figure 1) and 6 (11.3%) had a 
significant decrease (p<0.05) in adequate reporting since 
the SPIRIT statement (online supplementary appendix 
C). Twenty- three individual checklist items were inade-
quately or not reported in more than half of all RCT proto-
cols (figure 2). Only one checklist item was adequately 
reported in all 300 RCT protocols—‘background and 
rationale: description and justification of research ques-
tion’. None of the 300 RCT protocols adequately reported 
all individual checklist items from the SPIRIT statement 
and no individual checklist items were inadequately or 
not reported in all 300 RCT protocols.
Table 2 shows the multiple regression analysis of the 
association between author, trial and journal factors and 
the reporting quality of RCT protocols. The final model 
had an adjusted R2 value of 0.37, indicating that 37% 
of the variability in SPIRIT score was explained in our 
model. Author self- reported compliance with the SPIRIT 
statement was not associated with actual compliance with 
the SPIRIT statement. However, publicly reported journal 
policy of compliance with the SPIRIT statement was 
associated with significantly improved reporting quality. 
Industry funding was not associated with compliance with 
the SPIRIT statement, with only a 0.3% (95% CI, −4.9% to 
–5.6%, p=0.9) difference in mean SPIRIT scores between 
industry- funded and non- industry- funded trials. Similarly, 
publication type (either print or exclusively online) was 
not associated with compliance with the SPIRIT state-
ment (p=0.29). As such, industry funding and publication 
type were not included in the regression analysis as our 
preplanned regression modelling limited the inclusion of 
variables to only those with potential statistical influence.
DISCUSSION
Key results
We assessed the reporting quality of published RCT 
protocols before and after the SPIRIT statement. We 
found a significant improvement in the completeness 
of RCT protocols published since the SPIRIT statement. 
Although our study suggests significant improvements in 
the overall reporting quality of RCT protocols published 
after the SPIRIT statement, these significant improve-
ments were only seen in 40% (21/53) of individual check-
list items, and there were no RCT protocols in which all 
individual checklist items were complete.
Limitations
Our study is limited by the lack of blinding of data 
collectors to the date of publication of RCT protocols, 
introducing the possibility for researcher bias. This 
was minimised through strict adherence to predefined 
parameters for the assessment of the checklist items from 
Figure 1 Checklist items with a significant increase in adequate reporting after the SPIRIT statement. SPIRIT, Standard 
Protocol Items: Recommendations for Interventional Trials.
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the SPIRIT statement, fortnightly round- table meetings 
and duplication of data collection for one- third of RCT 
protocols. Our study was also limited by the inclusion of 
only RCT protocols published in the English language.
The associations found in this study may not be causal, 
and the improvements in overall reporting quality may be 
due to underlying secular trends whereby RCT protocol 
quality improves over time, unrelated to the introduc-
tion of the SPIRIT statement. However, the association 
between specific journal requirement for the SPIRIT 
statement, and reporting to that requirement, suggests 
some degree of causation. Additionally, while none of 
the 300 RCT protocols adequately reported all individual 
checklist items from the SPIRIT statement, some check-
list items may not be relevant to all RCT protocols and 
thus the level of under- reporting observed here may be a 
slight overestimate.
Interpretation
Despite the significant improvement in the overall 
reporting quality of RCT protocols suggested by our 
study, three individual checklist items from the SPIRIT 
statement were inadequately or not reported by more 
than 90% of RCT protocols: ‘consent or assent: ancil-
lary studies’, ‘dissemination policy: authorship eligibility 
guidelines and any intended use of professional writers’ 
and ‘informed consent materials’.
The low completeness of checklist item ‘consent or 
assent: ancillary studies’ may be related to a misper-
ception by authors that it is not necessary to report the 
decision that participant data or biological specimens 
will not be used in ancillary studies. However, deciding 
and reporting on the provisions of additional consent 
for ancillary studies is important, particularly given the 
increasing emphasis on data sharing plans. A similar 
sentiment may explain the low completeness of checklist 
item ‘informed consent materials: model consent form 
and other related documentation given to participants 
and authorised surrogates’, as authors may consider it 
sufficient to describe a plan to obtain informed consent 
and not necessary to provide the model consent form. 
However, providing the model consent form is important 
in determining that the relevant information is delivered 
with sufficient detail at an appropriate literacy level for the 
target population. Additionally, the low completeness of 
checklist item ‘dissemination policy: authorship eligibility 
guidelines and any intended use of professional writers’ 
may be underpinned by an underappreciation of the 
importance of disclosing the use of professional writers. 
A study of industry- initiated RCTs reported that 91% of 
44 RCT protocols had evidence of ghost authorship.12
The factors associated with higher reporting quality of 
RCT protocols in multiple regression analysis were one 
Figure 2 Completeness of randomised controlled trial protocols by checklist items, before and after the SPIRIT statement. 
SPIRIT, Standard Protocol Items: Recommendations for Interventional Trials.
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or more authors with expertise or experience in epide-
miology or statistics, multicentre trials, longer protocol 
word length and publicly reported journal policy of 
compliance with the SPIRIT statement. The association 
between author expertise or experience in epidemiology 
or statistics, and higher reporting quality has previously 
been reported16 and may be related to education in the 
importance of transparency and experience in writing 
RCT protocols. In a similar way, the association between 
multicentre trials and higher reporting quality may be 
explained by the larger nature of these studies and, by 
extension, the greater level of support available to these 
studies for writing the protocol and greater importance 
of transparently and completely reporting the protocol. 
Additionally, the association between longer protocol 
word lengths and higher reporting quality may be under-
pinned by the capacity to more completely describe a 
planned RCT with more permitted words. This would 
support a more discretionary, individualised approach to 
determining appropriate word lengths of RCT protocols, 
rather than arbitrary, blanket cut- offs.
Interestingly, protocol report of compliance with 
the SPIRIT statement was not a significant predictor of 
reporting quality after adjusting for publicly reported 
journal policy of compliance with the SPIRIT statement. 
A possible explanation for this finding is that some 
authors who are aware of either the SPIRIT statement 
or the journal’s policy of compliance with the SPIRIT 
statement may decide to self- report compliance with the 
SPIRIT statement without actually applying the checklist. 
This suggests that author self- report of compliance with 
the SPIRIT statement cannot be relied on as a proxy indi-
cator of reporting quality as awareness of the SPIRIT state-
ment does not translate into application of the checklist. 
Rather, the association between publicly reported journal 
policy of compliance with the SPIRIT statement and 
higher reporting quality supports the role of journals and 
editors in checking adherence to the SPIRIT statement 
to improve the completeness and transparency of RCT 
protocols. Some possible aids for journals and editors 
checking adherence to the SPIRIT statement include 
mandated author completed presubmission checklists, 
structured online manuscript submission systems and 
automated manuscript reporting quality checks. Other 
avenues include incorporating the SPIRIT statement into 
the mandatory fields required by clinical trial registries 
(eg,  ClinicalTrials. gov, ANZCTR and ISRCTN). This is 
particularly relevant, given many trials may be registered 
but do not have published protocols.
The findings from our research expand on those of 
Gao et al (2016), who assessed the reporting quality of 
142 RCT protocols in acupuncture using the checklist 
items from the SPIRIT statement.17 However, we found 
a substantially larger number of checklist items whose 
completeness significantly improved after the SPIRIT 
statement (5 in Gao et al (2016) and 21 in our study).17 
This difference may be explained by the time since the 
SPIRIT statement; while Gao et al (2016) assessed RCT 
protocols published 1 to 2 years after the SPIRIT state-
ment, our study assessed RCT protocols published 6 to 
7 years after the SPIRIT statement. This could suggest 
increasing awareness and adoption of the SPIRIT state-
ment over time. More recently, Yang et al (2018) assessed 
the reporting quality of 126 trial protocols in anaesthesia 
against the SPIRIT statement, and found no significant 
improvement in the completeness of trial protocols 
published after the SPIRIT statement and substantially 
more checklist items which were inadequately or not 
reported by more than 90% of included trial protocols 
(18 by Yang et al (2018) and 3 in our study). However, 
their findings were limited by the small sample size of 18 
trial protocols from after the SPIRIT statement.18
Overall, there remains substantial opportunity for 
further improvement. A study of emergency medicine 
journals found that reporting guidelines, including the 
SPIRIT statement, were infrequently endorsed,19 and a 
scoping review of systematic reviews of adherence to other 
reporting guidelines reported insufficient adherence.20 
These findings suggest that the challenges to improving 
adherence to the SPIRIT statement are shared with other 
reporting guidelines. The focus should be on increasing 
the awareness of the SPIRIT statement throughout the 
research community, particularly among trial investiga-
tors, and promoting the adoption of the SPIRIT statement 
in the editorial community, specifically by advocating for 
Table 2 Multiple regression analysis of author, trial and 
journal characteristics associated with the reporting quality 
of RCT protocols
Increase in proportion 
of adequately reported 
checklist items from 
the SPIRIT statement
P 
value
Author characteristics
  Number of authors per 
protocol
0.2% 0.004
  One or more authors 
with expertise 
or experience in 
epidemiology or 
statistics
2.6% 0.016
Trial characteristics
  Multicentre status 4.6% 0.000
  Protocol word length 
>3500
6.5% 0.000
  Protocols self- reporting 
compliance with the 
SPIRIT statement
– 0.145
Journal characteristics
  Journal policy of 
compliance with the 
SPIRIT statement
6.2% 0.000
RCT, randomised controlled trial; SPIRIT, Standard Protocol Items: 
Recommendations for Interventional Trials.
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mandated adherence to reporting guidelines. Improving 
the reporting quality of RCT protocols is necessary to 
improve the completeness and transparency of RCTs, and, 
by extension, the validity and reliability of RCT outcomes 
which ultimately contribute to informing patient care. 
It is likely that continued and concerted efforts by jour-
nals, editors, reviewers and investigators to advocate for 
adherence to the SPIRIT statement would improve the 
completeness and transparency of RCT protocols.
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